Cite

HARVARD Citation

    Belaunzaran, O. et al. (n.d.). 216 Anti-tumor activity of iosH2 by blocking LILRB2 receptor signalling. Journal for immunotherapy of cancer. p. A129. [Online]. 
  
Back to record